|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03692 HANSOH PHARMA
Nominal 
0.000 (0.000%) | 2024/12 - Final RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | 3,862,355 | 3,116,468 | 2,741,205 | 2,577,062 | 2,390,479 |
| Net Cash from / (used in) Investing Activities | (1,391,792) | 1,073,972 | (5,935,073) | (2,259,157) | (2,874,127) |
| Net Cash from / (used in) Financing Activities | (6,065,945) | (753,695) | (818,144) | 3,416,776 | (1,035,628) |
| Increase / (Decrease) in Cash & Cash Equivalents | (3,595,382) | 3,436,745 | (4,012,012) | 3,734,681 | (1,519,276) |
| Cash & Cash Equivalents at beginning of period | 5,980,513 | 2,666,132 | 6,718,709 | 3,063,316 | 5,344,859 |
| Effect of Foreign Exchange Rate Changes | (62,430) | (122,364) | (40,565) | (79,288) | (762,267) |
| Others | 0 | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | 2,322,701 | 5,980,513 | 2,666,132 | 6,718,709 | 3,063,316 |
| Remarks: | Real time quote last updated: 28/10/2025 07:38 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 3,134,929 |
| %Change | 15.021% |
| EPS / (LPS) | RMB 0.530 |
| NBV Per Share (¥) | RMB 5.229 |